Mint tablets (Mentha piperitae tablets)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Similar drugsTo uncover
Dosage form: & nbsplozenges
Composition:

For one tablet:

Active ingredient:

Peppermint oil (Mint pepper leaf oil)

0.0025 grams

Excipients:

Sugar (sucrose)

0.5917 g

Talc

0.0029 grams

Calcium stearate

0.0029 grams

Weight of a tablet

0.6 g
Description:

Tablets of flat-cylindrical form with a facet and a risk, white color, with a characteristic smell.

Pharmacotherapeutic group:Spasmolytic agent of plant origin
ATX: & nbsp
  • Preparations for the treatment of functional disorders of the digestive tract
    • Pharmacodynamics:

    Has moderate spasmolytic, sedative and choleretic effect. It has a local irritating effect on the nerve endings of the oral mucosa.

    Pharmacokinetics:
    Indications:

    Applied as a symptomatic for nausea, vomiting, spastic pain of the organs of the gastrointestinal tract.

    Contraindications:

    Hypersensitivity to the components of the drug, inflammatory diseases of the oral mucosa, a deficiency of sugar / isomaltase, intolerance to fructose, glucose-galactose malabsorption, age to 8 years.

    Carefully:

    Diabetes mellitus, cholelithiasis, children age over 8 years.

    People on a diet with a low carbohydrate content.

    If you have any of these diseases, consult a doctor before taking the drug.
    Pregnancy and lactation:

    It is not recommended to use during pregnancy and during breastfeeding due to the lack of special studies.

    Dosing and Administration:

    Apply 1-2 tablets 3-4 times a day. The tablets are kept in the mouth until complete resorption. The maximum daily dose is 8 tablets. The course of treatment without a doctor's consultation is 3 days.

    Side effects:

    Allergic reactions, irritation of the oral mucosa are possible.

    In case of adverse reactions, the drug should be discontinued.

    If any of the side effects listed in the manual are aggravated, or if you notice any other side effects not listed in the instructions, inform the doctor about it.

    Overdose:To date, no cases of overdose have been observed.
    Interaction:

    Not studied.

    Special instructions:

    People on a diet with a reduced carbohydrate diet should take into account that one tablet contains about 0.59 g of carbohydrates (0.05 XE).

    Effect on the ability to drive transp. cf. and fur:

    The use of the drug does not affect the ability to perform potentially dangerous activities requiring increased concentration of attention and speed of psychomotor reactions (vehicle management, work with moving mechanisms).

    Form release / dosage:Lozenges.
    Packaging:

    10 tablets per contour cell pack.

    1, 2, 3 or 5 contour mesh packages together with the instruction for use are placed in a pack of cardboard.

    50 contour mesh Packages together with an equal number of instructions for use are placed in a box or in a cardboard box (for hospitals).

    Storage conditions:

    In a dry place, at a temperature not exceeding 15 ° ะก.

    Keep out of the reach of children.

    Shelf life:

    2 years.

    Do not use after the expiration date.

    Terms of leave from pharmacies:Without recipe
    Registration number:LP-002547
    Date of registration:28.07.2014
    Expiration Date:28.07.2019
    Date of cancellation:2019-07-28
    The owner of the registration certificate:VIFITEH, CJSC VIFITEH, CJSC Russia
    Manufacturer: & nbsp
    Representation: & nbspVIFITEH, CJSCVIFITEH, CJSC
    Information update date: & nbsp21.05.2018
    Illustrated instructions
      Instructions
      Up